The drug of abuse testing market is expanding steadily, driven by the growing prevalence of substance use, strict regulatory mandates, and increased workplace and clinical testing. With innovations like AI-powered diagnostics and rapid test kits, the market is forecast to grow at a 5.15% CAGR, reaching over USD 23 billion by 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Drug of Abuse Testing Market Revenue and Volume, by Drug Type
7.1.1. Alcohol
7.1.1.1. Market Revenue and Volume Forecast
7.1.2. Cocaine
7.1.2.1. Market Revenue and Volume Forecast
7.1.3. Marijuana/Cannabis
7.1.3.1. Market Revenue and Volume Forecast
7.1.4. LSD
7.1.4.1. Market Revenue and Volume Forecast
7.1.5. Opioids
7.1.5.1. Market Revenue and Volume Forecast
7.1.6. Others
7.1.6.1. Market Revenue and Volume Forecast
8.1. Drug of Abuse Testing Market Revenue and Volume, by Sample Type
8.1.1. Urine
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Saliva
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Blood
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Hair
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Breath
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast
9.1. Drug of Abuse Testing Market Revenue and Volume, by Product
9.1.1. Equipment
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Consumables
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Rapid Testing Devices
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Laboratory testing services
9.1.4.1. Market Revenue and Volume Forecast
10.1. Drug of Abuse Testing Market Revenue and Volume, by Application
10.1.1. Medical Screening
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Monitoring Pain Management
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Forensic & Legal Information
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Employment Drug Testing
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Sports & Athletics Testing
10.1.5.1. Market Revenue and Volume Forecast
11.1. Drug of Abuse Testing Market Revenue and Volume, by End User
11.1.1. Workplaces
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Criminal Justice Systems
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Hospitals
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Research Labs
11.1.4.1. Market Revenue and Volume Forecast
12.1. Drug of Abuse Testing Market Revenue and Volume, by Substance Tested
12.1.1. Substance (Marijuana/cannabis)
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Synthetic Drugs
12.1.2.1. Market Revenue and Volume Forecast
13.1. Drug of Abuse Testing Market Revenue and Volume, by Methodology
13.1.1. Immunoassay
13.1.1.1. Market Revenue and Volume Forecast
13.1.2. Gas-chromatography-mass spectrometry (GC-MS)
13.1.2.1. Market Revenue and Volume Forecast
13.1.3. Liquid chromatography-mass spectrometry(LC-MS)
13.1.3.1. Market Revenue and Volume Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Drug Type
14.1.2. Market Revenue and Volume Forecast, by Sample Type
14.1.3. Market Revenue and Volume Forecast, by Product
14.1.4. Market Revenue and Volume Forecast, by Application
14.1.5. Market Revenue and Volume Forecast, by End User
14.1.6. Market Revenue and Volume Forecast, by Methodology
14.1.7. Market Revenue and Volume Forecast, by Substance Tested
14.1.8. U.S.
14.1.8.1. Market Revenue and Volume Forecast, by Drug Type
14.1.8.2. Market Revenue and Volume Forecast, by Sample Type
14.1.8.3. Market Revenue and Volume Forecast, by Product
14.1.8.4. Market Revenue and Volume Forecast, by Application
14.1.8.5. Market Revenue and Volume Forecast, by End User
14.1.8.6. Market Revenue and Volume Forecast, by Methodology
14.1.8.7. Market Revenue and Volume Forecast, by Substance Tested
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Drug Type
14.1.9.2. Market Revenue and Volume Forecast, by Sample Type
14.1.9.3. Market Revenue and Volume Forecast, by Product
14.1.9.4. Market Revenue and Volume Forecast, by Application
14.1.9.5. Market Revenue and Volume Forecast, by End User
14.1.9.6. Market Revenue and Volume Forecast, by Methodology
14.1.9.7. Market Revenue and Volume Forecast, by Substance Tested
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Drug Type
14.2.2. Market Revenue and Volume Forecast, by Sample Type
14.2.3. Market Revenue and Volume Forecast, by Product
14.2.4. Market Revenue and Volume Forecast, by Application
14.2.5. Market Revenue and Volume Forecast, by End User
14.2.6. Market Revenue and Volume Forecast, by Methodology
14.2.7. Market Revenue and Volume Forecast, by Substance Tested
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Drug Type
14.2.8.2. Market Revenue and Volume Forecast, by Sample Type
14.2.8.3. Market Revenue and Volume Forecast, by Product
14.2.8.4. Market Revenue and Volume Forecast, by Application
14.2.8.5. Market Revenue and Volume Forecast, by End User
14.2.8.6. Market Revenue and Volume Forecast, by Methodology
14.2.8.7. Market Revenue and Volume Forecast, by Substance Tested
14.2.9. Germany
14.2.9.1. Market Revenue and Volume Forecast, by Drug Type
14.2.9.2. Market Revenue and Volume Forecast, by Sample Type
14.2.9.3. Market Revenue and Volume Forecast, by Product
14.2.9.4. Market Revenue and Volume Forecast, by Application
14.2.9.5. Market Revenue and Volume Forecast, by End User
14.2.9.6. Market Revenue and Volume Forecast, by Methodology
14.2.9.7. Market Revenue and Volume Forecast, by Substance Tested
14.2.10. France
14.2.10.1. Market Revenue and Volume Forecast, by Drug Type
14.2.10.2. Market Revenue and Volume Forecast, by Sample Type
14.2.10.3. Market Revenue and Volume Forecast, by Product
14.2.10.4. Market Revenue and Volume Forecast, by Application
14.2.10.5. Market Revenue and Volume Forecast, by End User
14.2.10.6. Market Revenue and Volume Forecast, by Methodology
14.2.10.7. Market Revenue and Volume Forecast, by Substance Tested
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Volume Forecast, by Drug Type
14.2.11.2. Market Revenue and Volume Forecast, by Sample Type
14.2.11.3. Market Revenue and Volume Forecast, by Product
14.2.11.4. Market Revenue and Volume Forecast, by Application
14.2.11.5. Market Revenue and Volume Forecast, by End User
14.2.11.6. Market Revenue and Volume Forecast, by Methodology
14.2.11.7. Market Revenue and Volume Forecast, by Substance Tested
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Drug Type
14.3.2. Market Revenue and Volume Forecast, by Sample Type
14.3.3. Market Revenue and Volume Forecast, by Product
14.3.4. Market Revenue and Volume Forecast, by Application
14.3.5. Market Revenue and Volume Forecast, by End User
14.3.6. Market Revenue and Volume Forecast, by Methodology
14.3.7. Market Revenue and Volume Forecast, by Substance Tested
14.3.8. India
14.3.8.1. Market Revenue and Volume Forecast, by Drug Type
14.3.8.2. Market Revenue and Volume Forecast, by Sample Type
14.3.8.3. Market Revenue and Volume Forecast, by Product
14.3.8.4. Market Revenue and Volume Forecast, by Application
14.3.8.5. Market Revenue and Volume Forecast, by End User
14.3.8.6. Market Revenue and Volume Forecast, by Methodology
14.3.8.7. Market Revenue and Volume Forecast, by Substance Tested
14.3.9. China
14.3.9.1. Market Revenue and Volume Forecast, by Drug Type
14.3.9.2. Market Revenue and Volume Forecast, by Sample Type
14.3.9.3. Market Revenue and Volume Forecast, by Product
14.3.9.4. Market Revenue and Volume Forecast, by Application
14.3.9.5. Market Revenue and Volume Forecast, by End User
14.3.9.6. Market Revenue and Volume Forecast, by Methodology
14.3.9.7. Market Revenue and Volume Forecast, by Substance Tested
14.3.10. Japan
14.3.10.1. Market Revenue and Volume Forecast, by Drug Type
14.3.10.2. Market Revenue and Volume Forecast, by Sample Type
14.3.10.3. Market Revenue and Volume Forecast, by Product
14.3.10.4. Market Revenue and Volume Forecast, by Application
14.3.10.5. Market Revenue and Volume Forecast, by End User
14.3.10.6. Market Revenue and Volume Forecast, by Methodology
14.3.10.7. Market Revenue and Volume Forecast, by Substance Tested
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Volume Forecast, by Drug Type
14.3.11.2. Market Revenue and Volume Forecast, by Sample Type
14.3.11.3. Market Revenue and Volume Forecast, by Product
14.3.11.4. Market Revenue and Volume Forecast, by Application
14.3.11.5. Market Revenue and Volume Forecast, by End User
14.3.11.6. Market Revenue and Volume Forecast, by Methodology
14.3.11.7. Market Revenue and Volume Forecast, by Substance Tested
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Drug Type
14.4.2. Market Revenue and Volume Forecast, by Sample Type
14.4.3. Market Revenue and Volume Forecast, by Product
14.4.4. Market Revenue and Volume Forecast, by Application
14.4.5. Market Revenue and Volume Forecast, by End User
14.4.6. Market Revenue and Volume Forecast, by Methodology
14.4.7. Market Revenue and Volume Forecast, by Substance Tested
14.4.8. GCC
14.4.8.1. Market Revenue and Volume Forecast, by Drug Type
14.4.8.2. Market Revenue and Volume Forecast, by Sample Type
14.4.8.3. Market Revenue and Volume Forecast, by Product
14.4.8.4. Market Revenue and Volume Forecast, by Application
14.4.8.5. Market Revenue and Volume Forecast, by End User
14.4.8.6. Market Revenue and Volume Forecast, by Methodology
14.4.8.7. Market Revenue and Volume Forecast, by Substance Tested
14.4.9. North Africa
14.4.9.1. Market Revenue and Volume Forecast, by Drug Type
14.4.9.2. Market Revenue and Volume Forecast, by Sample Type
14.4.9.3. Market Revenue and Volume Forecast, by Product
14.4.9.4. Market Revenue and Volume Forecast, by Application
14.4.9.5. Market Revenue and Volume Forecast, by End User
14.4.9.6. Market Revenue and Volume Forecast, by Methodology
14.4.9.7. Market Revenue and Volume Forecast, by Substance Tested
14.4.10. South Africa
14.4.10.1. Market Revenue and Volume Forecast, by Drug Type
14.4.10.2. Market Revenue and Volume Forecast, by Sample Type
14.4.10.3. Market Revenue and Volume Forecast, by Product
14.4.10.4. Market Revenue and Volume Forecast, by Application
14.4.10.5. Market Revenue and Volume Forecast, by End User
14.4.10.6. Market Revenue and Volume Forecast, by Methodology
14.4.10.7. Market Revenue and Volume Forecast, by Substance Tested
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Volume Forecast, by Drug Type
14.4.11.2. Market Revenue and Volume Forecast, by Sample Type
14.4.11.3. Market Revenue and Volume Forecast, by Product
14.4.11.4. Market Revenue and Volume Forecast, by Application
14.4.11.5. Market Revenue and Volume Forecast, by End User
14.4.11.6. Market Revenue and Volume Forecast, by Methodology
14.4.11.7. Market Revenue and Volume Forecast, by Substance Tested
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Drug Type
14.5.2. Market Revenue and Volume Forecast, by Sample Type
14.5.3. Market Revenue and Volume Forecast, by Product
14.5.4. Market Revenue and Volume Forecast, by Application
14.5.5. Market Revenue and Volume Forecast, by End User
14.5.6. Market Revenue and Volume Forecast, by Methodology
14.5.7. Market Revenue and Volume Forecast, by Substance Tested
14.5.8. Brazil
14.5.8.1. Market Revenue and Volume Forecast, by Drug Type
14.5.8.2. Market Revenue and Volume Forecast, by Sample Type
14.5.8.3. Market Revenue and Volume Forecast, by Product
14.5.8.4. Market Revenue and Volume Forecast, by Application
14.5.8.5. Market Revenue and Volume Forecast, by End User
14.5.8.6. Market Revenue and Volume Forecast, by Methodology
14.5.8.7. Market Revenue and Volume Forecast, by Substance Tested
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Drug Type
14.5.9.2. Market Revenue and Volume Forecast, by Sample Type
14.5.9.3. Market Revenue and Volume Forecast, by Product
14.5.9.4. Market Revenue and Volume Forecast, by Application
14.5.9.5. Market Revenue and Volume Forecast, by End User
14.5.9.6. Market Revenue and Volume Forecast, by Methodology
14.5.9.7. Market Revenue and Volume Forecast, by Substance Tested
15.1. Danaher Corporation
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. LabCorp
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Abbott Laboratories
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Quest Diagnostics, Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Cordant Health Solutions
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. DrugScan
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Legacy Medical Services
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Mayo Clinic Laboratories
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. LGC Group
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Precision Diagnostics
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description